These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10658570)

  • 1. New drugs-reports of new drugs recently approved by the FDA. Abacavir sulfate.
    Huff JR
    Bioorg Med Chem; 1999 Dec; 7(12):2667-9. PubMed ID: 10658570
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and conformational analysis of novel 2',3'-didehydo-2',3'-dideoxy-4'-selenonucleosides.
    Ko YJ; Choi WJ; Jun JH; Zhao LX; Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):555-6. PubMed ID: 18776500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-HIV activities of symmetrical dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
    Agarwal HK; Buckheit KW; Buckheit RW; Parang K
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5451-4. PubMed ID: 22858097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiated derivatives of 2',3'-dideoxy-3'-fluorothymidine: synthesis, in vitro anti-HIV-1 activity and interaction with recombinant drug resistant HIV-1 reverse transcriptase forms.
    Miazga A; Hamy F; Louvel S; Klimkait T; Pietrusiewicz Z; Kurzyńska-Kokorniak A; Figlerowicz M; Wińska P; Kulikowski T
    Antiviral Res; 2011 Oct; 92(1):57-63. PubMed ID: 21683097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drugs--reports of new drugs recently approved by the FDA. Lamivudine.
    Ohta Y; Shinkai I
    Bioorg Med Chem; 1997 Apr; 5(4):639-40. PubMed ID: 9158860
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase.
    Gavriliu D; Fossey C; Ciurea A; Delbederi Z; Sugeac E; Ladurée D; Schmidt S; Laumond G; Aubertin AM
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(8-9):505-33. PubMed ID: 12484448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abacavir sulfate (Ziagen).
    Simmons P
    Res Initiat Treat Action; 1999 Apr; 5(2):8-10. PubMed ID: 11366289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.
    Van Laethem K; Witvrouw M; Balzarini J; Schmit JC; Sprecher S; Hermans P; Leal M; Harrer T; Ruiz L; Clotet B; Van Ranst M; Desmyter J; De Clercq E; Vandamme AM
    AIDS; 2000 Mar; 14(4):469-71. PubMed ID: 10770556
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA approves abacavir. Food and Drug Administration.
    Highleyman L
    BETA; 1999 Jan; 12(1):3. PubMed ID: 11367235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiated analogues of 2',3'-dideoxy-3'-fluorothymidine and their phosphorylated and phosphonylated derivatives: synthesis, interaction with HIV reverse transcriptase, and in vitro anti-HIV activity.
    Miazga A; Felczak K; Bretner M; Siwecka MA; Piasek A; Kulikowski T
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):973-5. PubMed ID: 14565324
    [No Abstract]   [Full Text] [Related]  

  • 11. Syntheses and anti-HIV activities of (+/-)-norcarbovir and (+/-)-norabacavir.
    Huang W; Miller MJ; De Clercq E; Balzarini J
    Org Biomol Chem; 2007 Apr; 5(8):1164-6. PubMed ID: 17406712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abacavir (Ziagen).
    Res Initiat Treat Action; 2000 Mar; 6(1):16-7. PubMed ID: 11708178
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance to nucleoside reverse transcriptase inhibitors].
    Leal M; Santamaría JM
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):26-9. PubMed ID: 11428055
    [No Abstract]   [Full Text] [Related]  

  • 14. Abacavir in combination with the inosine monophosphate dehydrogenase (IMPDH)-inhibitor mycophenolic acid is active against multidrug-resistant HIV-1.
    Heredia A; Margolis D; Oldach D; Hazen R; Le N; Redfield R
    J Acquir Immune Defic Syndr; 1999 Dec; 22(4):406-7. PubMed ID: 10634204
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Abacavir sulfate tablets tentatively approved.
    AIDS Alert; 2011 May; 26(5):59-60. PubMed ID: 21648134
    [No Abstract]   [Full Text] [Related]  

  • 16. [AIDS drug in the correct form].
    Schenk M
    Dtsch Med Wochenschr; 1998 Sep; 123(36):A9. PubMed ID: 9765604
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agent.
    Ray AS; Yang Z; Chu CK; Anderson KS
    Antimicrob Agents Chemother; 2002 Mar; 46(3):887-91. PubMed ID: 11850281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA approves generic abacavir sulfate tablets.
    AIDS Alert; 2006 Dec; 21(12):139-40. PubMed ID: 17233093
    [No Abstract]   [Full Text] [Related]  

  • 19. Generic lamivudine and abacavir approved.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043839
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. Abacavir approved for pediatric patients.
    AIDS Alert; 2009 Feb; 24(2):21-2. PubMed ID: 19222148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.